Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.

Lignende værker

• Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box?
  af: Benna, Marouan, et al.
  Udgivet: (2020)
• Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
  af: Bo, Lulong, et al.
  Udgivet: (2011)
• Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
  af: Ardizzoni, A., et al.
  Udgivet: (1996)
• Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy
  af: WADHWA, M, et al.
  Udgivet: (1996)
• Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis
  af: Seledtsov, Victor Ivanovich, et al.
  Udgivet: (2019)